Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

Anticoagulation in the early phase of non-valvular atrial fibrillation-related acute ischemic stroke: where do we stand?

The balance between the risk of early stroke recurrence and haemorrhagiic transformation represents the cornerstone of practical management of non valvular atrial fibrillation (NVAF)-related acute ischemic stroke (AIS). Patients who receive antithrombotic therapy as secondary prevention in the earl...

Full description

Bibliographic Details
Main Authors: Luca Masotti, Elisa Grifoni, Alessandro Dei, Vieri Vannucchi, Federico Moroni, Grazia Panigada, Stefano Spolveri, Giancarlo Landini
Format: Article
Language:English
Published: PAGEPress Publications 2019-01-01
Series:Italian Journal of Medicine
Subjects:
Stroke
dabigatran
rivaroxaban
apixaban
edoxaban
direct oral anticoagulants.
Online Access:https://www.italjmed.org/index.php/ijm/article/view/1111

Internet

https://www.italjmed.org/index.php/ijm/article/view/1111

Similar Items